Navigating the pitfalls of applying machine learning in genomics

S Whalen, J Schreiber, WS Noble… - Nature Reviews Genetics, 2022 - nature.com
The scale of genetic, epigenomic, transcriptomic, cheminformatic and proteomic data
available today, coupled with easy-to-use machine learning (ML) toolkits, has propelled the …

Graph neural network approaches for drug-target interactions

Z Zhang, L Chen, F Zhong, D Wang, J Jiang… - Current Opinion in …, 2022 - Elsevier
Develo** new drugs remains prohibitively expensive, time-consuming, and often involves
safety issues. Accurate prediction of drug-target interactions (DTIs) can guide the drug …

Artificial intelligence in the prediction of protein–ligand interactions: recent advances and future directions

A Dhakal, C McKay, JJ Tanner… - Briefings in …, 2022 - academic.oup.com
New drug production, from target identification to marketing approval, takes over 12 years
and can cost around $2.6 billion. Furthermore, the COVID-19 pandemic has unveiled the …

DeepTraSynergy: drug combinations using multimodal deep learning with transformers

F Rafiei, H Zeraati, K Abbasi, JB Ghasemi… - …, 2023 - academic.oup.com
Motivation Screening bioactive compounds in cancer cell lines receive more attention.
Multidisciplinary drugs or drug combinations have a more effective role in treatments and …

Circular RNAs and complex diseases: from experimental results to computational models

CC Wang, CD Han, Q Zhao, X Chen - Briefings in bioinformatics, 2021 - academic.oup.com
Circular RNAs (circRNAs) are a class of single-stranded, covalently closed RNA molecules
with a variety of biological functions. Studies have shown that circRNAs are involved in a …

Machine learning approaches and databases for prediction of drug–target interaction: a survey paper

M Bagherian, E Sabeti, K Wang… - Briefings in …, 2021 - academic.oup.com
The task of predicting the interactions between drugs and targets plays a key role in the
process of drug discovery. There is a need to develop novel and efficient prediction …

Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases

AS Rifaioglu, H Atas, MJ Martin… - Briefings in …, 2019 - academic.oup.com
The identification of interactions between drugs/compounds and their targets is crucial for
the development of new drugs. In vitro screening experiments (ie bioassays) are frequently …

Updated review of advances in microRNAs and complex diseases: taxonomy, trends and challenges of computational models

L Huang, L Zhang, X Chen - Briefings in bioinformatics, 2022 - academic.oup.com
Since the problem proposed in late 2000s, microRNA–disease association (MDA)
predictions have been implemented based on the data fusion paradigm. Integrating diverse …

DeepAffinity: interpretable deep learning of compound–protein affinity through unified recurrent and convolutional neural networks

M Karimi, D Wu, Z Wang, Y Shen - Bioinformatics, 2019 - academic.oup.com
Motivation Drug discovery demands rapid quantification of compound–protein interaction
(CPI). However, there is a lack of methods that can predict compound–protein affinity from …

Predicting miRNA–disease association based on inductive matrix completion

X Chen, L Wang, J Qu, NN Guan, JQ Li - Bioinformatics, 2018 - academic.oup.com
Motivation It has been shown that microRNAs (miRNAs) play key roles in variety of
biological processes associated with human diseases. In Consideration of the cost and …